These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 21463341)
1. Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Inokuchi S; Tsukamoto H; Park E; Liu ZX; Brenner DA; Seki E Alcohol Clin Exp Res; 2011 Aug; 35(8):1509-18. PubMed ID: 21463341 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow and nonbone marrow Toll like receptor 4 regulate acute hepatic injury induced by endotoxemia. Hochhauser E; Avlas O; Fallach R; Bachmetov L; Zemel R; Pappo O; Shainberg A; Ben Ari Z PLoS One; 2013; 8(8):e73041. PubMed ID: 23977376 [TBL] [Abstract][Full Text] [Related]
3. The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis. Levin I; Petrasek J; Szabo G Alcohol Clin Exp Res; 2012 Aug; 36(8):1397-406. PubMed ID: 22376231 [TBL] [Abstract][Full Text] [Related]
4. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hritz I; Mandrekar P; Velayudham A; Catalano D; Dolganiuc A; Kodys K; Kurt-Jones E; Szabo G Hepatology; 2008 Oct; 48(4):1224-31. PubMed ID: 18792393 [TBL] [Abstract][Full Text] [Related]
5. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. De Minicis S; Seki E; Paik YH; Osterreicher CH; Kodama Y; Kluwe J; Torozzi L; Miyai K; Benedetti A; Schwabe RF; Brenner DA Hepatology; 2010 Oct; 52(4):1420-30. PubMed ID: 20690191 [TBL] [Abstract][Full Text] [Related]
6. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. Nagata K; Suzuki H; Sakaguchi S J Toxicol Sci; 2007 Dec; 32(5):453-68. PubMed ID: 18198478 [TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice: Role of Hepatic Stellate Cells. Kumar S; Wang J; Shanmukhappa SK; Gandhi CR Am J Pathol; 2017 Jun; 187(6):1356-1367. PubMed ID: 28412299 [TBL] [Abstract][Full Text] [Related]
8. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218 [TBL] [Abstract][Full Text] [Related]
9. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis. Chen SN; Tan Y; Xiao XC; Li Q; Wu Q; Peng YY; Ren J; Dong ML Acta Pharmacol Sin; 2021 Oct; 42(10):1610-1619. PubMed ID: 33495514 [TBL] [Abstract][Full Text] [Related]
10. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice. Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482 [TBL] [Abstract][Full Text] [Related]
12. Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice. Byun JS; Suh YG; Yi HS; Lee YS; Jeong WI J Hepatol; 2013 Feb; 58(2):342-9. PubMed ID: 23023014 [TBL] [Abstract][Full Text] [Related]
13. TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration. Roh YS; Zhang B; Loomba R; Seki E Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G30-41. PubMed ID: 25930080 [TBL] [Abstract][Full Text] [Related]
14. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Mandrekar P; Ambade A; Lim A; Szabo G; Catalano D Hepatology; 2011 Dec; 54(6):2185-97. PubMed ID: 21826694 [TBL] [Abstract][Full Text] [Related]
15. Toll-like Receptor 4 on Macrophage Promotes the Development of Steatohepatitis-related Hepatocellular Carcinoma in Mice. Miura K; Ishioka M; Minami S; Horie Y; Ohshima S; Goto T; Ohnishi H J Biol Chem; 2016 May; 291(22):11504-17. PubMed ID: 27022031 [TBL] [Abstract][Full Text] [Related]
16. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. Petrasek J; Bala S; Csak T; Lippai D; Kodys K; Menashy V; Barrieau M; Min SY; Kurt-Jones EA; Szabo G J Clin Invest; 2012 Oct; 122(10):3476-89. PubMed ID: 22945633 [TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Miura K; Kodama Y; Inokuchi S; Schnabl B; Aoyama T; Ohnishi H; Olefsky JM; Brenner DA; Seki E Gastroenterology; 2010 Jul; 139(1):323-34.e7. PubMed ID: 20347818 [TBL] [Abstract][Full Text] [Related]
18. CD14 is not required for carbon tetrachloride-induced hepatic inflammation and fibrosis with or without lipopolysaccharide challenge. Sharma A; Wang J; Gandhi CR J Cell Physiol; 2023 Jul; 238(7):1530-1541. PubMed ID: 37098757 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Miura K; Yang L; van Rooijen N; Brenner DA; Ohnishi H; Seki E Hepatology; 2013 Feb; 57(2):577-89. PubMed ID: 22987396 [TBL] [Abstract][Full Text] [Related]
20. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways. Zhao HW; Zhang ZF; Chai X; Li GQ; Cui HR; Wang HB; Meng YK; Liu HM; Wang JB; Li RS; Bai ZF; Xiao XH Int Immunopharmacol; 2016 Jul; 36():249-255. PubMed ID: 27179304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]